Exploring New Advances in Current & Novel Treatments
for the Management of Epilepsy

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session at the 2017 Spring Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from June 15, 2017 to August 1, 2018

Instructions for CME/CNE: Complete the pre test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This educational activity is supported by educational grants from
Eisai Inc., Sunovion, and UCB

Description:
Epilepsy is a chronic neurological disorder where the nerve cell activity in the brain becomes disrupted, causing seizures or periods of unusual behavior. Patients experiencing seizures, particularly those that are not easily controlled, need to seek out neurological guidance as more antiepileptic drugs (AEDs), in addition to anticonvulsants are becoming available. The goal for neurologists is to achieve a seizure-free status for their patients without adverse effects. Treatment of epilepsy involves reducing the number of seizures by administering various AEDs. This approach requires long-term adherence from patients. The development of new AEDs continues to increase and drug therapies can now be individualized to the patient’s symptoms and needs. Uncontrolled seizures and their associated comorbidities, such as depression, can have detrimental effects on the patient’s quality of life.

Upon Completion of this activity, participants will be able to:

  • Review the efficacy, safety, and mechanisms of action of current and emerging antiepileptic agents to develop treatment plans that optimize seizure control

  • Assess the latest developments in the diagnostic and physiologic barriers including seizure and epilepsy classification

  • Explore new advances in current and novel treatments for patients who are not responding adequately to first line therapies

  • Discuss strategies to address and reduce morbidity from adverse effects associated with the use of certain therapies

  • Explore proper adherence regimens by implementing strategies to enhance patient and caregiver knowledge about epilepsy
     

Faculty: Dennis J. Dlugos, MD
Professor of Neurology and Pediatrics
The Children’s Hospital of Philadelphia
University of Pennsylvania

Disclosure:

Dr. Dlugos receives grant/research support from the National Institutes of Health and the State of Pennsylvania Epilepsy Study Consortium. His presentation will include various AED's that are used off label in children. His presentation has been peer reviewed.
 
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Will Williams has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.
Jacquelyn Smith has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation

The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This educational activity is supported by educational grants from
Eisai Inc., Sunovion, and UCB

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue